{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:10:47Z","timestamp":1763057447465,"version":"3.33.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1136\/ard.2007.085910","type":"journal-article","created":{"date-parts":[[2008,4,24]],"date-time":"2008-04-24T00:54:34Z","timestamp":1208998474000},"page":"337-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The B lymphocyte stimulator receptor\u2013ligand system in hepatitis C virus-induced B cell clonal disorders"],"prefix":"10.1016","volume":"68","author":[{"given":"D-A","family":"Landau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rosenzwajg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Klatzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.085910_bib1","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.085910_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1097-0215(20000715)87:2<211::AID-IJC9>3.0.CO;2-8","article-title":"Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process.","volume":"87","author":"De Re","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1136\/ard.2007.085910_bib3","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2003-07-2598","article-title":"CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.","volume":"103","author":"Boyer","year":"2004","journal-title":"Blood"},{"key":"10.1136\/ard.2007.085910_bib4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation.","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.085910_bib5","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/art.21270","article-title":"Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.","volume":"52","author":"Saadoun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.085910_bib6","first-page":"79","article-title":"Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases.","volume":"28","author":"Gorevic","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1136\/ard.2007.085910_bib7","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin\u2019s lymphoma: systematic review and meta-analysis.","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1136\/ard.2007.085910_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.085910_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"key":"10.1136\/ard.2007.085910_bib10","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.","volume":"297","author":"Giordano","year":"2007","journal-title":"JAMA"},{"key":"10.1136\/ard.2007.085910_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2036.2005.02395.x","article-title":"Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection.","volume":"21","author":"Gisbert","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1136\/ard.2007.085910_bib12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.gastro.2005.12.039","article-title":"Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.","volume":"130","author":"Pal","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1136\/ard.2007.085910_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/viro.1996.0644","article-title":"Suppression of apoptotic cell death by hepatitis C virus core protein.","volume":"226","author":"Ray","year":"1996","journal-title":"Virology"},{"key":"10.1136\/ard.2007.085910_bib14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.","volume":"4","author":"Moriya","year":"1998","journal-title":"Nat Med"},{"key":"10.1136\/ard.2007.085910_bib15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81.","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1136\/ard.2007.085910_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2249.2002.01844.x","article-title":"Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.","volume":"128","author":"Zuckerman","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2007.085910_bib17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0168-8278(03)00075-8","article-title":"Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver.","volume":"38","author":"Curry","year":"2003","journal-title":"J Hepatol"},{"key":"10.1136\/ard.2007.085910_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0168-8278(00)00063-5","article-title":"High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.","volume":"34","author":"Realdon","year":"2001","journal-title":"J Hepatol"},{"key":"10.1136\/ard.2007.085910_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas.","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2007.085910_bib20","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.173.5.3549","article-title":"Frequent joining of Bcl-2 to a JH6 gene in hepatitis C virus-associated t(14;18).","volume":"173","author":"Sasso","year":"2004","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.085910_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1172\/JCI18025","article-title":"BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.","volume":"112","author":"Avery","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2007.085910_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","article-title":"BAFF: a fundamental survival factor for B cells.","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2007.085910_bib23","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1002\/art.21489","article-title":"Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus.","volume":"52","author":"Carter","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.085910_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/039463200702000101","article-title":"BAFF and rheumatic autoimmune disorders: implications for disease management and therapy.","volume":"20","author":"Bosello","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1136\/ard.2007.085910_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","article-title":"BAFF is elevated in serum of patients with Wegener\u2019s granulomatosis.","volume":"25","author":"Krumbholz","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.2007.085910_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.2005.01688.x","article-title":"The BAFF\/APRIL system in systemic autoimmune diseases with a special emphasis on Sj\u00f6gren\u2019s syndrome.","volume":"62","author":"Szodoray","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1136\/ard.2007.085910_bib27","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","article-title":"BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.","volume":"103","author":"Moreaux","year":"2004","journal-title":"Blood"},{"key":"10.1136\/ard.2007.085910_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-472X(01)00774-3","article-title":"BLyS and BLyS receptor expression in non-Hodgkin\u2019s lymphoma.","volume":"30","author":"Briones","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1136\/ard.2007.085910_bib29","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.172.5.3268","article-title":"Lymphoma B cells evade apoptosis through the TNF family members BAFF\/BLyS and APRIL.","volume":"172","author":"He","year":"2004","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.085910_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/kel177","article-title":"Hepatitis C virus-associated B-cell proliferation\u2014the role of serum B lymphocyte stimulator (BLyS\/BAFF).","volume":"46","author":"Sene","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.085910_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaut.2006.07.005","article-title":"Elevated serum B-lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity.","volume":"27","author":"Toubi","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.2007.085910_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/rheumatology\/kel174","article-title":"B-lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection.","volume":"46","author":"Fabris","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.085910_bib33","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/clinchem\/38.6.798","article-title":"Characterization of cryoglobulins by immunoblotting.","volume":"38","author":"Musset","year":"1992","journal-title":"Clin Chem"},{"key":"10.1136\/ard.2007.085910_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.085910_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-3083.1999.00524.x","article-title":"Molecular characterization of the VH1-specific variable region determinants recognized by anti-idiotypic monoclonal antibodies G6 and G8.","volume":"50","author":"Potter","year":"1999","journal-title":"Scand J Immunol"},{"key":"10.1136\/ard.2007.085910_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V97.1.198","article-title":"Synthesis and release of B-lymphocyte stimulator from myeloid cells.","volume":"97","author":"Nardelli","year":"2001","journal-title":"Blood"},{"key":"10.1136\/ard.2007.085910_bib37","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.174.10.6532","article-title":"Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis.","volume":"174","author":"Carbonari","year":"2005","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.085910_bib38","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.molimm.2006.08.021","article-title":"VCAM-1-positive stromal cells from human bone marrow producing cytokines for B lineage progenitors and for plasma cells: SDF-1, flt3L, and BAFF.","volume":"44","author":"Schaumann","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1136\/ard.2007.085910_bib39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/ard.2006.065656","article-title":"Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus.","volume":"66","author":"Sellam","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.085910_bib40","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1182\/blood-2005-10-4042","article-title":"Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.","volume":"107","author":"Fu","year":"2006","journal-title":"Blood"},{"key":"10.1136\/ard.2007.085910_bib41","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood-2004-02-0762","article-title":"Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.","volume":"104","author":"Novak","year":"2004","journal-title":"Blood"},{"key":"10.1136\/ard.2007.085910_bib42","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.192.7.953","article-title":"Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.","volume":"192","author":"Do","year":"2000","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2007.085910_bib43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2141.2001.02573.x","article-title":"bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection.","volume":"112","author":"Zuckerman","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1136\/ard.2007.085910_bib44","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1136\/ard.2007.085910_bib45","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2006.060772","article-title":"Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production.","volume":"66","author":"Lavie","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.085910_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/ar1222","article-title":"The current status of targeting BAFF\/BLyS for autoimmune diseases.","volume":"6","author":"Ramanujam","year":"2004","journal-title":"Arthritis Res Ther"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724425867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724425867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.085910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:17:11Z","timestamp":1737263831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724425867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0003496724425867"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.085910","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The B lymphocyte stimulator receptor\u2013ligand system in hepatitis C virus-induced B cell clonal disorders","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.085910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 2009 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}